Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AZN AstraZeneca	$69.63 +0.3%	$70.77	$61.24 ▼ $87.68	$215.39B	0.37	5.24 million shs	4.44 million shs
AZN AstraZeneca	$69.63 +0.3%	$70.77	$61.24 ▼ $87.68	$215.39B	0.37	5.24 million shs	4.44 million shs
AZNCF AstraZeneca	$142.63 +1.4%	$141.89	$120.64 ▼ $175.00	N/A	N/A	2,250 shs	1,939 shs
INTU Intuit	$783.61 +0.4%	$722.21	$532.65 ▼ $790.60	$217.76B	1.27	1.61 million shs	1.29 million shs
SGHC Super Group (SGHC)	$11.39	$9.25	$2.94 ▼ $11.48	$5.73B	1.09	757,716 shs	1.80 million shs
WIX Wix.com	$163.68 -0.4%	$162.09	$137.94 ▼ $247.11	$9.22B	1.31	686,772 shs	467,227 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AZN AstraZeneca	+0.04%	-0.36%	-4.46%	+7.29%	-9.97%
AZN AstraZeneca	+0.04%	-0.36%	-4.46%	+7.29%	-9.97%
AZNCF AstraZeneca	+1.38%	+3.22%	-1.17%	+7.73%	-4.08%
INTU Intuit	+0.17%	-0.51%	+1.56%	+44.03%	+17.18%
SGHC Super Group (SGHC)	+1.82%	+3.64%	+23.74%	+75.64%	+255.94%
WIX Wix.com	-0.30%	+3.29%	+7.46%	+9.41%	+6.14%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AZN AstraZeneca	2.2924 of 5 stars	2.4	3.0	1.7	0.0	2.8	0.0	1.3
AZN AstraZeneca	2.2924 of 5 stars	2.4	3.0	1.7	0.0	2.8	0.0	1.3
AZNCF AstraZeneca	0.2751 of 5 stars	0.0	1.0	1.7	0.0	1.7	0.8	0.0
INTU Intuit	4.4688 of 5 stars	2.4	3.0	3.3	3.0	2.8	2.5	1.3
SGHC Super Group (SGHC)	3.1152 of 5 stars	2.6	3.0	2.5	0.0	2.1	0.8	1.9
WIX Wix.com	4.6669 of 5 stars	4.5	2.0	0.0	2.6	2.7	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AZN AstraZeneca	2.83	Moderate Buy	$85.00	22.07% Upside
AZN AstraZeneca	2.83	Moderate Buy	$85.00	22.07% Upside
AZNCF AstraZeneca	0.00	N/A	N/A	N/A
INTU Intuit	2.88	Moderate Buy	$798.27	1.87% Upside
SGHC Super Group (SGHC)	3.17	Buy	$11.83	3.89% Upside
WIX Wix.com	3.00	Buy	$228.95	39.87% Upside

Current Analyst Ratings Breakdown

Latest AZN, SGHC, WIX, INTU, AZN, and AZNCF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/7/2025	INTU Intuit	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$785.00 ➝ $900.00
6/26/2025	INTU Intuit	CLSA Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$900.00
6/20/2025	WIX Wix.com	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$250.00
6/18/2025	WIX Wix.com	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$200.00
6/16/2025	WIX Wix.com	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$173.00 ➝ $216.00
6/13/2025	INTU Intuit	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$825.00 ➝ $880.00
6/11/2025	SGHC Super Group (SGHC)	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$9.00 ➝ $11.00
5/28/2025	WIX Wix.com	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$240.00 ➝ $230.00
5/23/2025	INTU Intuit	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Positive ➝ Positive
5/23/2025	INTU Intuit	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$642.00 ➝ $742.00
5/23/2025	INTU Intuit	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$775.00 ➝ $825.00

(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AZN AstraZeneca	$54.07B	3.99	$6.31 per share	11.03	$13.18 per share	5.28
AZN AstraZeneca	$54.07B	3.99	$6.31 per share	11.03	$13.18 per share	5.28
AZNCF AstraZeneca	N/A	N/A	N/A	N/A	N/A	N/A
INTU Intuit	$18.18B	12.02	$14.64 per share	53.53	$65.77 per share	11.91
SGHC Super Group (SGHC)	$1.84B	3.12	$0.52 per share	21.75	$1.19 per share	9.57
WIX Wix.com	$1.76B	5.22	$3.14 per share	52.13	($1.40) per share	-116.91

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AZN AstraZeneca	$7.04B	$2.49	27.96	13.93	1.28	14.14%	33.14%	12.83%	7/29/2025 (Estimated)
AZN AstraZeneca	$7.04B	$2.49	27.96	13.93	1.28	14.14%	33.14%	12.83%	7/29/2025 (Estimated)
AZNCF AstraZeneca	N/A	$0.82	174.79	∞	N/A	N/A	N/A	N/A	7/29/2025 (Estimated)
INTU Intuit	$2.96B	$12.32	63.60	48.85	3.47	19.07%	21.46%	11.99%	8/20/2025 (Estimated)
SGHC Super Group (SGHC)	$122.38M	$0.27	42.19	23.24	N/A	7.02%	33.88%	19.33%	8/6/2025 (Estimated)
WIX Wix.com	$138.32M	$2.51	65.21	32.28	2.62	8.16%	-80.80%	8.85%	8/6/2025 (Estimated)

Latest AZN, SGHC, WIX, INTU, AZN, and AZNCF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/29/2025	Q2 2025	AZN AstraZeneca	$1.11	N/A	N/A	N/A	$14.08 billion	N/A
7/29/2025	Q2 2025	AZN AstraZeneca	$1.11	N/A	N/A	N/A	$14.08 billion	N/A
5/22/2025	Q3 2025	INTU Intuit	$10.89	$11.65	+$0.76	$10.02	$7.56 billion	$7.75 billion
5/8/2025	Q1 2025	SGHC Super Group (SGHC)	$0.09	$0.12	+$0.03	$0.12	$423.91 million	$495.96 million
4/29/2025	Q1 2025	AZN AstraZeneca	$1.10	$1.24	+$0.14	$0.93	$13.71 billion	$13.59 billion
4/29/2025	Q1 2025	AZN AstraZeneca	$1.10	$1.24	+$0.14	$0.93	$13.71 billion	$13.59 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AZN AstraZeneca	$2.06	2.96%	N/A	82.73%	N/A
AZN AstraZeneca	$2.06	2.96%	N/A	82.73%	N/A
AZNCF AstraZeneca	$2.80	1.96%	N/A	343.14%	N/A
INTU Intuit	$4.16	0.53%	N/A	33.77%	13 Years
SGHC Super Group (SGHC)	$0.16	1.40%	N/A	59.26%	N/A
WIX Wix.com	N/A	N/A	N/A	N/A	N/A

Latest AZN, SGHC, WIX, INTU, AZN, and AZNCF Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/20/2025	INTU Intuit	quarterly	$1.04	0.6%	7/10/2025	7/10/2025	7/18/2025
6/17/2025	SGHC Super Group (SGHC)	quarterly	$0.04	1.6%	6/23/2025	6/23/2025	6/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AZN AstraZeneca	0.65	0.90	0.70
AZN AstraZeneca	0.65	0.90	0.70
AZNCF AstraZeneca	N/A	N/A	N/A
INTU Intuit	0.29	1.45	1.45
SGHC Super Group (SGHC)	N/A	1.42	1.42
WIX Wix.com	N/A	0.79	0.79

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AZN AstraZeneca	20.35%
AZN AstraZeneca	20.35%
AZNCF AstraZeneca	40.87%
INTU Intuit	83.66%
SGHC Super Group (SGHC)	5.09%
WIX Wix.com	81.52%

Insider Ownership

Company	Insider Ownership
AZN AstraZeneca	N/A
AZN AstraZeneca	N/A
AZNCF AstraZeneca	N/A
INTU Intuit	2.68%
SGHC Super Group (SGHC)	10.41%
WIX Wix.com	6.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AZN AstraZeneca	94,300	3.10 billion	N/A	Optionable
AZN AstraZeneca	94,300	3.10 billion	N/A	Optionable
AZNCF AstraZeneca	83,500	N/A	N/A	Not Optionable
INTU Intuit	18,800	278.95 million	271.47 million	Optionable
SGHC Super Group (SGHC)	3,300	503.41 million	451.00 million	Optionable
WIX Wix.com	4,568	56.11 million	52.63 million	Optionable

AZN, SGHC, WIX, INTU, AZN, and AZNCF Headlines

Recent News About These Companies

Teacher Retirement System of Texas Buys 2,291 Shares of Wix.com Ltd. (NASDAQ:WIX)

4 hours ago | marketbeat.com

Vontobel Holding Ltd. Purchases New Stake in Wix.com Ltd. (NASDAQ:WIX)

July 7 at 3:59 AM | marketbeat.com

Wix.com Ltd. (NASDAQ:WIX) Shares Sold by Calamos Advisors LLC

July 6 at 5:34 AM | marketbeat.com

Wix.com (NASDAQ:WIX) Upgraded to Strong-Buy at Wall Street Zen

July 6 at 3:10 AM | americanbankingnews.com

VELA Investment Management LLC Grows Stake in Wix.com Ltd. (NASDAQ:WIX)

July 5 at 8:09 AM | marketbeat.com

Wix.com (NASDAQ:WIX) Upgraded by Wall Street Zen to "Strong-Buy" Rating

July 5 at 2:59 AM | marketbeat.com

Alibaba and Wix join forces, promise great things for SMBs

July 4, 2025 | msn.com

Harel Insurance Investments & Financial Services Ltd. Boosts Holdings in Wix.com Ltd. (NASDAQ:WIX)

July 4, 2025 | marketbeat.com

Wix.com Ltd. (NASDAQ:WIX) Shares Sold by Sumitomo Mitsui Trust Group Inc.

July 4, 2025 | marketbeat.com

2 Reasons to Sell WIX and 1 Stock to Buy Instead

July 3, 2025 | finance.yahoo.com

Alibaba.com and Wix announce partnership to support digital entrepreneurs

July 3, 2025 | enterprisetimes.co.ukE

Alibaba, Wix.com announce strategic partnership to accel growth for SMEs

July 3, 2025 | finance.yahoo.com

Wix Stock Surges After Alibaba Partnership to Boost Global E-Commerce for Small Merchants

July 3, 2025 | techstory.inT

Wix Partners With Alibaba to Power SMEs in Global Markets

July 3, 2025 | zacks.com

WCM Investment Management LLC Lowers Position in Wix.com Ltd. (NASDAQ:WIX)

July 3, 2025 | marketbeat.com

Wix and Alibaba form partnership to boost global reach for SMEs

July 3, 2025 | in.investing.com

Wix and Alibaba form partnership to boost global reach for SMEs

July 3, 2025 | in.investing.com

Alibaba Teams Up With Wix to Give Firms Global Reach

July 3, 2025 | marketwatch.com

Alibaba Teams Up With Wix to Give Firms Global Reach

July 3, 2025 | marketwatch.com

Alibaba, Wix Team up to Simplify Cross-Border Wholesale Connections

July 3, 2025 | retailtouchpoints.comR

Alibaba, Wix Team up to Simplify Cross-Border Wholesale Connections

July 3, 2025 | retailtouchpoints.comR

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?
By Leo Miller | June 19, 2025
View Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?

AZN, SGHC, WIX, INTU, AZN, and AZNCF Company Descriptions

AstraZeneca NASDAQ:AZN

$69.63 +0.18 (+0.26%)

Closing price 07/7/2025 04:00 PM Eastern

Extended Trading

$69.15 -0.48 (-0.69%)

As of 07:33 AM Eastern

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

AstraZeneca NASDAQ:AZN

$69.63 +0.18 (+0.26%)

Closing price 07/7/2025 04:00 PM Eastern

Extended Trading

$69.15 -0.48 (-0.69%)

As of 07:33 AM Eastern

AstraZeneca OTCMKTS:AZNCF

$142.63 +1.95 (+1.38%)

As of 07/7/2025 03:14 PM Eastern

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Intuit NASDAQ:INTU

$783.61 +2.97 (+0.38%)

Closing price 07/7/2025 04:00 PM Eastern

Extended Trading

$784.68 +1.07 (+0.14%)

As of 07:57 AM Eastern

Intuit Inc. provides financial management and compliance products and services for consumers, small businesses, self-employed, and accounting professionals in the United States, Canada, and internationally. The company operates in four segments: Small Business & Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business & Self-Employed segment provides QuickBooks services, that includes financial and business management online services and desktop software, payroll solutions, time tracking, merchant payment processing solutions, and financing for small businesses; and Mailchimp services, such as e-commerce, marketing automation, and customer relationship management. This segment also offers QuickBooks online services and desktop software solutions comprising QuickBooks Online Advanced, a cloud-based solution; QuickBooks Enterprise, a hosted solution; and QuickBooks Self-Employed solution; payment-processing solutions, including credit and debit cards, Apple Pay, and ACH payment services; and financial supplies and financing for small businesses, as well as electronic filing of federal and state income tax returns. The Consumer segment provides TurboTax income tax preparation products and services. The Credit Karma segment offers consumers with a personal finance platform that provides personalized recommendations of home, auto, and personal loans, as well as credit cards and insurance products. The ProTax segment provides Lacerte, ProSeries, and ProFile desktop tax-preparation software products; and ProConnect Tax Online tax products, electronic tax filing service, and bank products and related services. It sells products and services through various sales and distribution channels, including multi-channel shop-and-buy experiences, websites and call centers, mobile application stores, and retail and other channels. The company was founded in 1983 and is headquartered in Mountain View, California.

Super Group (SGHC) NYSE:SGHC

$11.39 0.00 (0.00%)

Closing price 07/7/2025 03:59 PM Eastern

Extended Trading

$11.48 +0.08 (+0.75%)

As of 07:54 AM Eastern

Super Group (SGHC) Limited operates as an online sports betting and gaming operator. It offers Betway, an online sports betting brand; and Spin, a multi-brand online casino offering. Super Group (SGHC) Limited is based in Saint Peter Port, Guernsey.

Wix.com NASDAQ:WIX

$163.68 -0.61 (-0.37%)

Closing price 07/7/2025 04:00 PM Eastern

Extended Trading

$165.00 +1.32 (+0.81%)

As of 07:53 AM Eastern

Wix.com Ltd., together with its subsidiaries, operates as a cloud-based web development platform for registered users and creators worldwide. The company offers Wix Editor, a drag-and-drop visual development and website editing environment platform; and Wix ADI that enables users to have the freedom of customization that the classic editor offers. It also provides Wix Logo Maker that generates a logo, including through the use of artificial intelligence; Wix Answers to support users; and Payments by Wix, a payment platform, which helps its users receive payments from their customers through their Wix Website. In addition, the company offers various vertical-specific applications that business owners use to operate various aspects of their business online. Further, it provides a range of complementary services, including Wix App Market, a marketplace that offers its registered users various free and paid web applications for building, growing, and managing their businesses; Wix marketplace that brings users seeking help in creating and managing a website together with Web experts; and Wix owner App, a native mobile application, which enables users to manage their Websites and Wix operating systems. The company was formerly known as Wixpress Ltd. The company was incorporated in 2006 and is headquartered in Tel Aviv, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AZN, SGHC, WIX, INTU, AZN, and AZNCF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AZN, SGHC, WIX, INTU, AZN, and AZNCF Earnings

Compare Dividends

Latest AZN, SGHC, WIX, INTU, AZN, and AZNCF Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AZN, SGHC, WIX, INTU, AZN, and AZNCF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AZN, SGHC, WIX, INTU, AZN, and AZNCF Company Descriptions

AstraZeneca NASDAQ:AZN

AstraZeneca NASDAQ:AZN

AstraZeneca OTCMKTS:AZNCF

Intuit NASDAQ:INTU

Super Group (SGHC) NYSE:SGHC

Wix.com NASDAQ:WIX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools